The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The competing risk approach for prediction of preeclampsia
Abstract
The established method of assessing the risk for development of preeclampsia (PE) is to identify risk factors from maternal demographic characteristics and medical history; in the presence of such factors the patient is classified as high-risk and in their absence as low-risk. Although this approach is simple to perform, it has poor performance of predicting PE and does not provide patient-specific risks. This review describes a new approach which allows estimation of patient-specific risks of delivery with PE before any specified gestational age by maternal demographic characteristics and medical history with biomarkers obtained either individually or in combination at any stage in pregnancy. In the competing risks approach every woman has a personalized distribution of gestational age at delivery with PE and whether she develops PE or not before a specified gestational age depends on competition between delivery before or after development of PE. The personalized distribution comes from the application of Bayes theorem to combine a prior distribution, determined from maternal factors, with likelihoods from biomarkers. As new data become available, what were posterior probabilities take the role as the prior and data collected at different stages are combined by repeating the application of Bayes theorem to form a new posterior at each stage allowing for dynamic prediction of PE. The competing risk model can be used for precision medicine and risk stratification at different stages of pregnancy. In the first-trimester, the model has been applied to identify a high-risk group that would benefit from preventative therapeutic interventions. In the second-trimester, the model has been used to stratify the population into high- intermediate- and low-risk groups in need of different intensities of subsequent monitoring thereby minimizing unexpected adverse perinatal events. The competing risks model can also be used in surveillance of women presenting to specialist clinics with signs or symptoms of hypertensive disorders; combination of maternal factors and biomarkers provide patient-specific risks for PE leading to personalized stratification of the intensity of monitoring with risks updated on each visit on the basis of biomarker measurements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Self-citationThe Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
The Statistical Analysis of Failure Time Data
Borgan, Ø. (2003) · Journal of the American Statistical Association · doi:10.1198/jasa.2003.s310 · Cited by 799
Koopmans, C. M., Bijlenga, D., Groen, H., Vijgen, S. M., Aarnoudse, J. G., Bekedam, D. J., van den Berg, P. P., de Boer, K., Burggraaff, J. M., Bloemenkamp, K. W., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60736-4 · Cited by 794
O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L. C., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.034 · Cited by 629
Self-citationAspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Self-citation
Cited by
Dimitriadis, E., Rolnik, D. L., Zhou, W., Estrada-Gutierrez, G., Koga, K., Francisco, R. P. V., Whitehead, C., Hyett, J., da Silva Costa, F., Nicolaides, K., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00417-6 · Cited by 866
Self-citationMagee, L. A., Nicolaides, K. H., & von Dadelszen, P. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2109523 · Cited by 546
Self-citationPapastefanou, I., Wright, D., Lolos, M., Anampousi, K., Mamalis, M., & Nicolaides, K. H. (2021) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.23118 · Cited by 40
Self-citationMalone, S. L., Haj Yahya, R., & Kane, S. C. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s283239 · Cited by 32
Metadata
- Authors
- Wright, D., Wright, A., & Nicolaides, K. H.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 223
- Issue
- 1
- Pages
- 12-23.e7
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2986009663
- Cited by
- 263
- References
- 62
- FWCI
- 24.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The competing risk approach for prediction of preeclampsia. https://app.cochat.ai/papers/10.1016/j.ajog.2019.11.1247
- The paper
- Wright, D., Wright, A., & Nicolaides, K. H. (2020). The competing risk approach for prediction of preeclampsia. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2019.11.1247
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.